“ur finding enables the safe discontinuation of follow-up after 6 years, leading to an improvement in quality of life and a reduction in health care system costs,” study researchers wrote.

Patients with recurring prostate cancer who were treated with a new PSMA-targeted radioligand therapy before stereotactic ...

In her new book 'As a Jew,' the former White House speechwriter confronts the challenges of appreciating Jewish tradition at ...

A research team in Japan has developed an innovative system that can accurately detect genetic mutations in brain tumors ...

19-year-old Ritsala Thonger, Contestant No.16 was crowned Miss Kohima 2025 at the Regional Centre of Excellence for Music & ...

The ESC has published a scientific statement regarding heart failure with preserved ejection fraction in patients with cancer and cancer survivors.

Scientists at Virginia Tech's Fralin Biomedical Research Institute at VTC and their collaborators are exploring emerging ...

In a new book, the former White House speechwriter says it’s time for Jews to reclaim their story from the haters.

Positioning starts by understanding those who make, influence or experience treatment decisions – patients, physicians, ...

In a new book, the former White House speechwriter says it's time for Jews to reclaim their story from the haters.

A significant advancement in skin cancer treatment has arrived. The US FDA has approved cemiplimab, known as Libtayo, to help ...

The Nasdaq Closing Bell ceremony will take place at the Nasdaq MarketSite, 4 Times Square, New York, beginning at 3:45 PM ET on October 14, 2025. The ceremony can be viewed live at ...